MICHAEL JAY SILLERS
- Type
- Physician · Allopathic & Osteopathic Physicians / Internal Medicine
- Where
- HOOVER, AL
- NPI
- 1205806213
- Received
- $288,364 in 263 records, 2019 to 2025 ($52,596 general, $235,768 research)
- As principal investigator
- $135,604 of research payments to others in 28 records
- Source
- CMS Open Payments search ↗
By year
| Program year | Kind | Records | Amount |
|---|---|---|---|
| 2025 | General payment | 46 | $8,500 |
| 2024 | General payment | 36 | $19,604 |
| 2024 | Research payment | 7 | $36,890 |
| 2023 | General payment | 37 | $734 |
| 2023 | Research payment | 8 | $135,110 |
| 2022 | General payment | 47 | $1,074 |
| 2022 | Research payment | 4 | $63,768 |
| 2021 | General payment | 47 | $20,954 |
| 2020 | General payment | 17 | $1,218 |
| 2019 | General payment | 14 | $510 |
By company
| Company | Records | Amount | Years |
|---|---|---|---|
| Neurent Medical Limited | 29 | $262,063 | 2022–2025 |
| AERIN MEDICAL INC. | 12 | $19,878 | 2020–2025 |
| Medtronic USA, Inc. | 2 | $1,116 | 2019–2020 |
| Optinose US, Inc. | 73 | $1,048 | 2019–2025 |
| GlaxoSmithKline, LLC. | 48 | $939 | 2021–2025 |
| Regeneron Healthcare Solutions, Inc. | 31 | $786 | 2019–2025 |
| Medtronic, Inc. | 3 | $728 | 2021–2024 |
| GENZYME CORPORATION | 23 | $597 | 2019–2025 |
| Stryker Corporation | 4 | $313 | 2019–2022 |
| ALK-Abello, Inc | 13 | $298 | 2019–2023 |
| Intersect ENT, Inc. | 7 | $171 | 2021–2022 |
| ABBVIE INC. | 5 | $99 | 2021–2023 |
| Amgen Inc. | 3 | $82 | 2025 |
| KARL STORZ Endoscopy-America | 1 | $61 | 2019 |
| Acclarent, Inc | 2 | $44 | 2019–2023 |
| Aimmune Therapeutics, Inc. | 1 | $26 | 2021 |
| Olympus America Inc. | 1 | $23 | 2019 |
| Merck Sharp & Dohme LLC | 1 | $20 | 2023 |
| Hikma Pharmaceuticals USA | 1 | $18 | 2022 |
| Paratek Pharmaceuticals, Inc. | 1 | $16 | 2025 |
| Ambu Inc. | 1 | $14 | 2025 |
| Ethicon US, LLC | 1 | $12 | 2020 |
By nature of payment
| Nature | Records | Amount |
|---|---|---|
| Research payment | 19 | $235,768 |
| Honoraria | 5 | $19,500 |
| Consulting Fee | 4 | $14,687 |
| Travel and Lodging | 2 | $12,008 |
| Food and Beverage | 231 | $5,416 |
| Compensation for serving as faculty or as a speaker for a non-accredited and noncertified continuing | 1 | $950 |
| Education | 1 | $34 |
Records
| Date | Company | Amount | Nature | Form | Product | Study | Year |
|---|---|---|---|---|---|---|---|
| 2025-12-16 | Regeneron Healthcare Solutions, Inc. | $23 | Food and Beverage | In-kind items and services | DUPIXENT Biological, IMMUNOLOGY AND INFLAMMATION | 2025 | |
| 2025-12-09 | GlaxoSmithKline, LLC. | $21 | Food and Beverage | In-kind items and services | NUCALA Biological, IMMUNOLOGY | 2025 | |
| 2025-12-02 | Amgen Inc. | $26 | Food and Beverage | In-kind items and services | TEZSPIRE Biological, Inflammation | 2025 | |
| 2025-11-18 | Regeneron Healthcare Solutions, Inc. | $34 | Food and Beverage | In-kind items and services | DUPIXENT Biological, IMMUNOLOGY AND INFLAMMATION | 2025 | |
| 2025-11-10 | Paratek Pharmaceuticals, Inc. | $16 | Food and Beverage | In-kind items and services | XHANCE Drug, CORTICOSTEROID | 2025 | |
| 2025-10-14 | GlaxoSmithKline, LLC. | $20 | Food and Beverage | In-kind items and services | NUCALA Biological, IMMUNOLOGY | 2025 | |
| 2025-10-07 | GENZYME CORPORATION | $33 | Food and Beverage | In-kind items and services | DUPIXENT Biological, Immunology | 2025 | |
| 2025-10-01 | Neurent Medical Limited | $19 | Food and Beverage | Cash or cash equivalent | NEUROMARK System Device, Electrosurgical, Cutting & Coagulation & Accessories | 2025 | |
| 2025-09-30 | GENZYME CORPORATION | $38 | Food and Beverage | In-kind items and services | DUPIXENT Biological, Immunology | 2025 | |
| 2025-09-24 | GlaxoSmithKline, LLC. | $23 | Food and Beverage | In-kind items and services | NUCALA Biological, IMMUNOLOGY | 2025 | |
| 2025-09-23 | Regeneron Healthcare Solutions, Inc. | $25 | Food and Beverage | In-kind items and services | DUPIXENT Biological, IMMUNOLOGY AND INFLAMMATION | 2025 | |
| 2025-09-02 | Amgen Inc. | $22 | Food and Beverage | In-kind items and services | 2025 | ||
| 2025-08-26 | GlaxoSmithKline, LLC. | $23 | Food and Beverage | In-kind items and services | NUCALA Biological, IMMUNOLOGY | 2025 | |
| 2025-08-19 | Regeneron Healthcare Solutions, Inc. | $24 | Food and Beverage | In-kind items and services | DUPIXENT Biological, IMMUNOLOGY AND INFLAMMATION | 2025 | |
| 2025-08-12 | Amgen Inc. | $34 | Education | In-kind items and services | 2025 | ||
| 2025-08-12 | GlaxoSmithKline, LLC. | $17 | Food and Beverage | In-kind items and services | NUCALA Biological, IMMUNOLOGY | 2025 | |
| 2025-07-30 | Optinose US, Inc. | $25 | Food and Beverage | In-kind items and services | Xhance Drug, Otolaryngology (Ear, Nose, Throat) | 2025 | |
| 2025-07-23 | Ambu Inc. | $14 | Food and Beverage | Cash or cash equivalent | 2025 | ||
| 2025-07-22 | AERIN MEDICAL INC. | $96 | Food and Beverage | In-kind items and services | VIVAER STYLUS Device, EAR NOSE & THROAT | 2025 | |
| 2025-07-22 | Regeneron Healthcare Solutions, Inc. | $30 | Food and Beverage | In-kind items and services | DUPIXENT Biological, IMMUNOLOGY AND INFLAMMATION | 2025 | |
| 2025-07-15 | GlaxoSmithKline, LLC. | $23 | Food and Beverage | In-kind items and services | NUCALA Biological, IMMUNOLOGY | 2025 | |
| 2025-07-08 | GENZYME CORPORATION | $40 | Food and Beverage | In-kind items and services | DUPIXENT Biological, Immunology | 2025 | |
| 2025-07-01 | GlaxoSmithKline, LLC. | $21 | Food and Beverage | In-kind items and services | NUCALA Biological, IMMUNOLOGY | 2025 | |
| 2025-06-24 | GlaxoSmithKline, LLC. | $23 | Food and Beverage | In-kind items and services | NUCALA Biological, IMMUNOLOGY | 2025 | |
| 2025-06-13 | Neurent Medical Limited | $6,000 | Consulting Fee | Cash or cash equivalent | NEUROMARK System Device, Electrosurgical, Cutting & Coagulation & Accessories | 2025 | |
| 2025-06-13 | Neurent Medical Limited | $1,348 | Travel and Lodging | Cash or cash equivalent | NEUROMARK System Device, Electrosurgical, Cutting & Coagulation & Accessories | 2025 | |
| 2025-06-03 | Optinose US, Inc. | $23 | Food and Beverage | In-kind items and services | Xhance Drug, Otolaryngology (Ear, Nose, Throat) | 2025 | |
| 2025-05-28 | GlaxoSmithKline, LLC. | $23 | Food and Beverage | In-kind items and services | NUCALA Biological, IMMUNOLOGY | 2025 | |
| 2025-05-20 | Regeneron Healthcare Solutions, Inc. | $26 | Food and Beverage | In-kind items and services | DUPIXENT Biological, IMMUNOLOGY AND INFLAMMATION | 2025 | |
| 2025-05-13 | GENZYME CORPORATION | $28 | Food and Beverage | In-kind items and services | DUPIXENT Biological, Immunology | 2025 | |
| 2025-05-06 | GlaxoSmithKline, LLC. | $17 | Food and Beverage | In-kind items and services | NUCALA Biological, IMMUNOLOGY | 2025 | |
| 2025-04-23 | GlaxoSmithKline, LLC. | $23 | Food and Beverage | In-kind items and services | NUCALA Biological, IMMUNOLOGY | 2025 | |
| 2025-04-22 | Regeneron Healthcare Solutions, Inc. | $22 | Food and Beverage | In-kind items and services | DUPIXENT Biological, IMMUNOLOGY AND INFLAMMATION | 2025 | |
| 2025-04-08 | GlaxoSmithKline, LLC. | $18 | Food and Beverage | In-kind items and services | NUCALA Biological, IMMUNOLOGY | 2025 | |
| 2025-04-01 | GENZYME CORPORATION | $40 | Food and Beverage | In-kind items and services | DUPIXENT Biological, Immunology | 2025 | |
| 2025-03-18 | Regeneron Healthcare Solutions, Inc. | $29 | Food and Beverage | In-kind items and services | DUPIXENT Biological, IMMUNOLOGY AND INFLAMMATION | 2025 | |
| 2025-03-04 | GlaxoSmithKline, LLC. | $23 | Food and Beverage | In-kind items and services | NUCALA Biological, IMMUNOLOGY | 2025 | |
| 2025-02-26 | GlaxoSmithKline, LLC. | $28 | Food and Beverage | In-kind items and services | NUCALA Biological, IMMUNOLOGY | 2025 | |
| 2025-02-25 | GENZYME CORPORATION | $30 | Food and Beverage | In-kind items and services | DUPIXENT Biological, Immunology | 2025 | |
| 2025-02-18 | Optinose US, Inc. | $17 | Food and Beverage | In-kind items and services | Xhance Drug, Otolaryngology (Ear, Nose, Throat) | 2025 | |
| 2025-02-11 | Regeneron Healthcare Solutions, Inc. | $30 | Food and Beverage | In-kind items and services | DUPIXENT Biological, IMMUNOLOGY AND INFLAMMATION | 2025 | |
| 2025-02-04 | GlaxoSmithKline, LLC. | $23 | Food and Beverage | In-kind items and services | NUCALA Biological, IMMUNOLOGY | 2025 | |
| 2025-01-21 | Regeneron Healthcare Solutions, Inc. | $27 | Food and Beverage | In-kind items and services | DUPIXENT Biological, IMMUNOLOGY AND INFLAMMATION | 2025 | |
| 2025-01-21 | GlaxoSmithKline, LLC. | $12 | Food and Beverage | In-kind items and services | NUCALA Biological, IMMUNOLOGY | 2025 | |
| 2025-01-14 | GlaxoSmithKline, LLC. | $22 | Food and Beverage | In-kind items and services | NUCALA Biological, IMMUNOLOGY | 2025 | |
| 2025-01-14 | GENZYME CORPORATION | $6 | Food and Beverage | In-kind items and services | DUPIXENT Biological, Immunology | 2025 | |
| 2024-12-10 | GlaxoSmithKline, LLC. | $18 | Food and Beverage | In-kind items and services | NUCALA Biological, IMMUNOLOGY | 2024 | |
| 2024-12-03 | GENZYME CORPORATION | $23 | Food and Beverage | In-kind items and services | DUPIXENT Biological, Immunology | 2024 | |
| 2024-11-21 | GlaxoSmithKline, LLC. | $1 | Food and Beverage | In-kind items and services | NUCALA Biological, IMMUNOLOGY | 2024 | |
| 2024-11-19 | Regeneron Healthcare Solutions, Inc. | $33 | Food and Beverage | In-kind items and services | DUPIXENT Biological, INFLAMMATION AND IMMUNOLOGY | 2024 | |
| 2024-10-29 | GlaxoSmithKline, LLC. | $26 | Food and Beverage | In-kind items and services | NUCALA Biological, IMMUNOLOGY | 2024 | |
| 2024-10-22 | GENZYME CORPORATION | $36 | Food and Beverage | In-kind items and services | DUPIXENT Biological, Immunology | 2024 | |
| 2024-09-17 | Optinose US, Inc. | $25 | Food and Beverage | In-kind items and services | Xhance Drug, Otolaryngology (Ear, Nose, Throat) | 2024 | |
| 2024-09-17 | Regeneron Healthcare Solutions, Inc. | $7 | Food and Beverage | In-kind items and services | DUPIXENT Biological, INFLAMMATION AND IMMUNOLOGY | 2024 | |
| 2024-09-10 | GENZYME CORPORATION | $11 | Food and Beverage | In-kind items and services | DUPIXENT Biological, Immunology | 2024 | |
| 2024-09-04 | AERIN MEDICAL INC. | $22 | Food and Beverage | In-kind items and services | VIVAER STYLUS Device, EAR NOSE & THROAT | 2024 | |
| 2024-09-03 | GlaxoSmithKline, LLC. | $18 | Food and Beverage | In-kind items and services | NUCALA Biological, IMMUNOLOGY | 2024 | |
| 2024-08-20 | Regeneron Healthcare Solutions, Inc. | $29 | Food and Beverage | In-kind items and services | DUPIXENT Biological, INFLAMMATION AND IMMUNOLOGY | 2024 | |
| 2024-08-06 | GENZYME CORPORATION | $30 | Food and Beverage | In-kind items and services | DUPIXENT Biological, Immunology | 2024 | |
| 2024-07-30 | GlaxoSmithKline, LLC. | $22 | Food and Beverage | In-kind items and services | NUCALA Biological, IMMUNOLOGY | 2024 | |
| 2024-07-23 | Regeneron Healthcare Solutions, Inc. | $22 | Food and Beverage | In-kind items and services | DUPIXENT Biological, INFLAMMATION AND IMMUNOLOGY | 2024 | |
| 2024-07-13 | AERIN MEDICAL INC. | $139 | Food and Beverage | In-kind items and services | VIVAER STYLUS Device, EAR NOSE & THROAT | 2024 | |
| 2024-06-25 | GlaxoSmithKline, LLC. | $18 | Food and Beverage | In-kind items and services | NUCALA Biological, IMMUNOLOGY | 2024 | |
| 2024-06-18 | Regeneron Healthcare Solutions, Inc. | $26 | Food and Beverage | In-kind items and services | DUPIXENT Biological, INFLAMMATION AND IMMUNOLOGY | 2024 | |
| 2024-05-31 | Neurent Medical Limited | $10,449 | Research payment | Cash or cash equivalent | NEUROMARK Device Device, Electrosurgical, Cutting & Coagulation & Accessories | Clinical Evaluation of Safety and Efficacy for the NEUROMARK System in Subjects With Chronic Rhinitis (PARAGON) | 2024 |
| 2024-05-31 | Neurent Medical Limited | $9,540 | Research payment | Cash or cash equivalent | NEUROMARK Device Device, Electrosurgical, Cutting & Coagulation & Accessories | NEUROMARK Registry Study | 2024 |
| 2024-05-31 | Neurent Medical Limited | $472 | Research payment | Cash or cash equivalent | NEUROMARK Device Device, Electrosurgical, Cutting & Coagulation & Accessories | Nexus Study - Clinical Exploration of NEUROMARK System in Subjects With Chronic Rhinosinusitis (CRS) | 2024 |
| 2024-05-28 | GENZYME CORPORATION | $29 | Food and Beverage | In-kind items and services | DUPIXENT Biological, Immunology | 2024 | |
| 2024-05-21 | Regeneron Healthcare Solutions, Inc. | $30 | Food and Beverage | In-kind items and services | DUPIXENT Biological, INFLAMMATION AND IMMUNOLOGY | 2024 | |
| 2024-05-07 | GlaxoSmithKline, LLC. | $19 | Food and Beverage | In-kind items and services | NUCALA Biological, IMMUNOLOGY | 2024 | |
| 2024-04-16 | GlaxoSmithKline, LLC. | $21 | Food and Beverage | In-kind items and services | NUCALA Biological, IMMUNOLOGY | 2024 | |
| 2024-04-03 | Medtronic, Inc. | $20 | Food and Beverage | In-kind items and services | PROPEL Device, Otolaryngology (Ear, Nose, Throat) | 2024 | |
| 2024-04-02 | Neurent Medical Limited | $1,000 | Consulting Fee | Cash or cash equivalent | NEUROMARK Device Device, Electrosurgical, Cutting & Coagulation & Accessories | 2024 | |
| 2024-03-31 | Neurent Medical Limited | $10,660 | Travel and Lodging | Cash or cash equivalent | NEUROMARK Device Device, Electrosurgical, Cutting & Coagulation & Accessories | 2024 | |
| 2024-03-31 | Neurent Medical Limited | $7,000 | Consulting Fee | Cash or cash equivalent | NEUROMARK Device Device, Electrosurgical, Cutting & Coagulation & Accessories | 2024 | |
| 2024-03-26 | Optinose US, Inc. | $24 | Food and Beverage | In-kind items and services | Xhance Drug, Otolaryngology (Ear, Nose, Throat) | 2024 | |
| 2024-03-19 | GlaxoSmithKline, LLC. | $19 | Food and Beverage | In-kind items and services | NUCALA Biological, IMMUNOLOGY | 2024 | |
| 2024-03-18 | Neurent Medical Limited | $88 | Food and Beverage | Cash or cash equivalent | NEUROMARK Device Device, Electrosurgical, Cutting & Coagulation & Accessories | 2024 | |
| 2024-03-18 | Neurent Medical Limited | $34 | Food and Beverage | Cash or cash equivalent | NEUROMARK Device Device, Electrosurgical, Cutting & Coagulation & Accessories | 2024 | |
| 2024-03-18 | Neurent Medical Limited | $29 | Food and Beverage | Cash or cash equivalent | NEUROMARK Device Device, Electrosurgical, Cutting & Coagulation & Accessories | 2024 | |
| 2024-03-13 | Regeneron Healthcare Solutions, Inc. | $25 | Food and Beverage | In-kind items and services | DUPIXENT Biological, INFLAMMATION AND IMMUNOLOGY | 2024 | |
| 2024-02-29 | GlaxoSmithKline, LLC. | $20 | Food and Beverage | In-kind items and services | NUCALA Biological, IMMUNOLOGY | 2024 | |
| 2024-02-13 | Regeneron Healthcare Solutions, Inc. | $22 | Food and Beverage | In-kind items and services | DUPIXENT Biological, INFLAMMATION AND IMMUNOLOGY | 2024 | |
| 2024-02-07 | GENZYME CORPORATION | $23 | Food and Beverage | In-kind items and services | DUPIXENT Biological, Immunology | 2024 | |
| 2024-01-23 | GlaxoSmithKline, LLC. | $18 | Food and Beverage | In-kind items and services | NUCALA Biological, IMMUNOLOGY | 2024 | |
| 2024-01-12 | Neurent Medical Limited | $6,102 | Research payment | Cash or cash equivalent | NEUROMARK Device Device, Electrosurgical, Cutting & Coagulation & Accessories | Clinical Evaluation of Safety and Efficacy for the NEUROMARK System in Subjects With Chronic Rhinitis (PARAGON) | 2024 |
| 2024-01-12 | Neurent Medical Limited | $5,920 | Research payment | Cash or cash equivalent | NEUROMARK Device Device, Electrosurgical, Cutting & Coagulation & Accessories | NEUROMARK Registry Study | 2024 |
| 2024-01-12 | Neurent Medical Limited | $2,515 | Research payment | Cash or cash equivalent | NEUROMARK Device Device, Electrosurgical, Cutting & Coagulation & Accessories | Safety and Efficacy Study of the Neurent Medical NEUROMARK System in Subjects With Chronic Rhinitis (CLARITY) | 2024 |
| 2024-01-12 | Neurent Medical Limited | $1,892 | Research payment | Cash or cash equivalent | NEUROMARK Device Device, Electrosurgical, Cutting & Coagulation & Accessories | Nexus Study - Clinical Exploration of NEUROMARK System in Subjects With Chronic Rhinosinusitis (CRS) | 2024 |
| 2023-12-12 | Medtronic, Inc. | $20 | Food and Beverage | In-kind items and services | PROPEL Device, Otolaryngology (Ear, Nose, Throat) | 2023 | |
| 2023-12-05 | AERIN MEDICAL INC. | $25 | Food and Beverage | In-kind items and services | VIVAER STYLUS Device, EAR NOSE & THROAT | 2023 | |
| 2023-11-28 | GENZYME CORPORATION | $24 | Food and Beverage | In-kind items and services | DUPIXENT Biological, Immunology | 2023 | |
| 2023-11-28 | GlaxoSmithKline, LLC. | $6 | Food and Beverage | In-kind items and services | NUCALA Biological, IMMUNOLOGY | 2023 | |
| 2023-10-31 | Merck Sharp & Dohme LLC | $20 | Food and Beverage | In-kind items and services | 2023 | ||
| 2023-10-24 | GlaxoSmithKline, LLC. | $23 | Food and Beverage | In-kind items and services | NUCALA Biological, IMMUNOLOGY | 2023 | |
| 2023-10-20 | Neurent Medical Limited | $15,930 | Research payment | Cash or cash equivalent | NEUROMARK Device Device, Electrosurgical, Cutting & Coagulation & Accessories | NEUROMARK Registry Study | 2023 |
| 2023-10-20 | Neurent Medical Limited | $7,263 | Research payment | Cash or cash equivalent | NEUROMARK Device Device, Electrosurgical, Cutting & Coagulation & Accessories | Clinical Evaluation of Safety and Efficacy for the NEUROMARK System in Subjects With Chronic Rhinitis (PARAGON) | 2023 |
| 2023-10-20 | Neurent Medical Limited | $7,250 | Research payment | Cash or cash equivalent | NEUROMARK Device Device, Electrosurgical, Cutting & Coagulation & Accessories | Nexus Study - Clinical Exploration of NEUROMARK System in Subjects With Chronic Rhinosinusitis (CRS) | 2023 |
| 2023-10-20 | Neurent Medical Limited | $5,094 | Research payment | Cash or cash equivalent | NEUROMARK Device Device, Electrosurgical, Cutting & Coagulation & Accessories | Safety and Efficacy Study of the Neurent Medical NEUROMARK System in Subjects With Chronic Rhinitis (CLARITY) | 2023 |
| 2023-10-17 | Optinose US, Inc. | $22 | Food and Beverage | In-kind items and services | Xhance Drug, Otolaryngology (Ear, Nose, Throat) | 2023 | |
| 2023-10-03 | Regeneron Healthcare Solutions, Inc. | $20 | Food and Beverage | In-kind items and services | DUPIXENT Biological, INFLAMMATION AND IMMUNOLOGY | 2023 | |
| 2023-09-19 | GlaxoSmithKline, LLC. | $23 | Food and Beverage | In-kind items and services | NUCALA Biological, IMMUNOLOGY | 2023 | |
| 2023-09-12 | Optinose US, Inc. | $21 | Food and Beverage | In-kind items and services | Xhance Drug, Otolaryngology (Ear, Nose, Throat) | 2023 | |
| 2023-08-22 | ABBVIE INC. | $27 | Food and Beverage | In-kind items and services | UBRELVY Drug, NEUROSCIENCE | 2023 | |
| 2023-08-22 | GENZYME CORPORATION | $17 | Food and Beverage | In-kind items and services | DUPIXENT Biological, Immunology | 2023 | |
| 2023-08-15 | Optinose US, Inc. | $17 | Food and Beverage | In-kind items and services | Xhance Drug, Otolaryngology (Ear, Nose, Throat) | 2023 | |
| 2023-08-04 | Neurent Medical Limited | $34,087 | Research payment | Cash or cash equivalent | NEUROMARK Device Device, Electrosurgical, Cutting & Coagulation & Accessories | Clinical Evaluation of Safety and Efficacy for the NEUROMARK System in Subjects With Chronic Rhinitis (PARAGON) | 2023 |
| 2023-07-25 | GlaxoSmithKline, LLC. | $17 | Food and Beverage | In-kind items and services | NUCALA Biological, IMMUNOLOGY | 2023 | |
| 2023-07-11 | Optinose US, Inc. | $19 | Food and Beverage | In-kind items and services | Xhance Drug, Otolaryngology (Ear, Nose, Throat) | 2023 | |
| 2023-06-30 | Neurent Medical Limited | $13,703 | Research payment | Cash or cash equivalent | NEUROMARK Device Device, Electrosurgical, Cutting & Coagulation & Accessories | Safety and Efficacy Study of the Neurent Medical NEUROMARK System in Subjects With Chronic Rhinitis (CLARITY) | 2023 |
| 2023-06-27 | Regeneron Healthcare Solutions, Inc. | $20 | Food and Beverage | In-kind items and services | DUPIXENT Biological, INFLAMMATION AND IMMUNOLOGY | 2023 | |
| 2023-06-14 | Optinose US, Inc. | $21 | Food and Beverage | In-kind items and services | Xhance Drug, Otolaryngology (Ear, Nose, Throat) | 2023 | |
| 2023-05-24 | GlaxoSmithKline, LLC. | $18 | Food and Beverage | In-kind items and services | NUCALA Biological, IMMUNOLOGY | 2023 | |
| 2023-05-17 | Optinose US, Inc. | $19 | Food and Beverage | In-kind items and services | Xhance Drug, Otolaryngology (Ear, Nose, Throat) | 2023 | |
| 2023-04-26 | Optinose US, Inc. | $4 | Food and Beverage | In-kind items and services | Xhance Drug, Otolaryngology (Ear, Nose, Throat) | 2023 | |
| 2023-04-25 | GENZYME CORPORATION | $27 | Food and Beverage | In-kind items and services | DUPIXENT Biological, Immunology | 2023 | |
| 2023-04-19 | ALK-Abello, Inc | $20 | Food and Beverage | In-kind items and services | Odactra Drug, Allergy and Immunology | 2023 | |
| 2023-04-11 | Optinose US, Inc. | $16 | Food and Beverage | In-kind items and services | Xhance Drug, Otolaryngology (Ear, Nose, Throat) | 2023 | |
| 2023-04-06 | Regeneron Healthcare Solutions, Inc. | $23 | Food and Beverage | In-kind items and services | DUPIXENT Biological, INFLAMMATION AND IMMUNOLOGY | 2023 | |
| 2023-04-05 | GlaxoSmithKline, LLC. | $19 | Food and Beverage | In-kind items and services | NUCALA Biological, IMMUNOLOGY | 2023 | |
| 2023-03-29 | Acclarent, Inc | $30 | Food and Beverage | In-kind items and services | TruDi NAV Cable Device, Rhinology Otology Laryngology Neurosurgery | 2023 | |
| 2023-03-21 | Regeneron Healthcare Solutions, Inc. | $20 | Food and Beverage | In-kind items and services | DUPIXENT Biological, INFLAMMATION AND IMMUNOLOGY | 2023 | |
| 2023-03-14 | Optinose US, Inc. | $19 | Food and Beverage | In-kind items and services | Xhance Drug, Otolaryngology (Ear, Nose, Throat) | 2023 | |
| 2023-03-08 | ABBVIE INC. | $15 | Food and Beverage | In-kind items and services | UBRELVY Drug, NEUROSCIENCE | 2023 | |
| 2023-03-08 | Optinose US, Inc. | $4 | Food and Beverage | In-kind items and services | Xhance Drug, Otolaryngology (Ear, Nose, Throat) | 2023 | |
| 2023-02-28 | GENZYME CORPORATION | $21 | Food and Beverage | In-kind items and services | DUPIXENT Biological, Immunology | 2023 | |
| 2023-02-21 | Neurent Medical Limited | $35,053 | Research payment | Cash or cash equivalent | NEUROMARK Device Device, Electrosurgical, Cutting & Coagulation & Accessories | Clinical Evaluation of Safety and Efficacy for the NEUROMARK System in Subjects With Chronic Rhinitis (PARAGON) | 2023 |
| 2023-02-17 | Neurent Medical Limited | $16,730 | Research payment | Cash or cash equivalent | NEUROMARK Device Device, Electrosurgical, Cutting & Coagulation & Accessories | Safety and Efficacy Study of the Neurent Medical NEUROMARK System in Subjects With Chronic Rhinitis (CLARITY) | 2023 |
| 2023-02-15 | GlaxoSmithKline, LLC. | $22 | Food and Beverage | In-kind items and services | NUCALA Biological, IMMUNOLOGY | 2023 | |
| 2023-02-14 | Optinose US, Inc. | $21 | Food and Beverage | In-kind items and services | Xhance Drug, Otolaryngology (Ear, Nose, Throat) | 2023 | |
| 2023-01-24 | Optinose US, Inc. | $18 | Food and Beverage | In-kind items and services | Xhance Drug, Otolaryngology (Ear, Nose, Throat) | 2023 | |
| 2023-01-17 | GlaxoSmithKline, LLC. | $21 | Food and Beverage | In-kind items and services | NUCALA Biological, IMMUNOLOGY | 2023 | |
| 2023-01-10 | GENZYME CORPORATION | $20 | Food and Beverage | In-kind items and services | DUPIXENT Biological, Immunology | 2023 | |
| 2023-01-10 | AERIN MEDICAL INC. | $17 | Food and Beverage | In-kind items and services | VIVAER STYLUS Device, EAR NOSE & THROAT | 2023 | |
| 2022-12-20 | Optinose US, Inc. | $5 | Food and Beverage | In-kind items and services | Xhance Drug, Otolaryngology (Ear, Nose, Throat) | 2022 | |
| 2022-12-12 | GENZYME CORPORATION | $27 | Food and Beverage | In-kind items and services | DUPIXENT Biological, Immunology | 2022 | |
| 2022-12-06 | Optinose US, Inc. | $16 | Food and Beverage | In-kind items and services | Xhance Drug, Otolaryngology (Ear, Nose, Throat) | 2022 | |
| 2022-12-02 | Neurent Medical Limited | $20,287 | Research payment | Cash or cash equivalent | NEUROMARK Device Device, Electrosurgical, Cutting & Coagulation & Accessories | Clinical Evaluation of Safety and Efficacy for the NEUROMARK System in Subjects With Chronic Rhinitis (PARAGON) | 2022 |
| 2022-12-01 | GlaxoSmithKline, LLC. | $21 | Food and Beverage | In-kind items and services | NUCALA Biological, IMMUNOLOGY | 2022 | |
| 2022-11-28 | ABBVIE INC. | $28 | Food and Beverage | In-kind items and services | UBRELVY Drug, NEUROSCIENCE | 2022 | |
| 2022-11-22 | Hikma Pharmaceuticals USA | $18 | Food and Beverage | In-kind items and services | Ryaltris Drug, Pulmonary/Respiratory Diseases | 2022 | |
| 2022-11-08 | Optinose US, Inc. | $15 | Food and Beverage | In-kind items and services | Xhance Drug, Otolaryngology (Ear, Nose, Throat) | 2022 | |
| 2022-11-08 | Optinose US, Inc. | $2 | Food and Beverage | In-kind items and services | Xhance Drug, Otolaryngology (Ear, Nose, Throat) | 2022 | |
| 2022-11-03 | Optinose US, Inc. | $4 | Food and Beverage | In-kind items and services | Xhance Drug, Otolaryngology (Ear, Nose, Throat) | 2022 | |
| 2022-11-01 | Neurent Medical Limited | $35,365 | Research payment | Cash or cash equivalent | NEUROMARK Device Device, Electrosurgical, Cutting & Coagulation & Accessories | Safety and Efficacy Study of the Neurent Medical NEUROMARK System in Subjects With Chronic Rhinitis (CLARITY) | 2022 |
| 2022-11-01 | GENZYME CORPORATION | $17 | Food and Beverage | In-kind items and services | DUPIXENT Biological, Immunology | 2022 | |
| 2022-10-25 | GlaxoSmithKline, LLC. | $16 | Food and Beverage | In-kind items and services | NUCALA Biological, IMMUNOLOGY | 2022 | |
| 2022-10-13 | Optinose US, Inc. | $4 | Food and Beverage | In-kind items and services | Xhance Drug, Otolaryngology (Ear, Nose, Throat) | 2022 | |
| 2022-10-05 | Optinose US, Inc. | $22 | Food and Beverage | In-kind items and services | Xhance Drug, Otolaryngology (Ear, Nose, Throat) | 2022 | |
| 2022-09-30 | Neurent Medical Limited | $3,908 | Research payment | Cash or cash equivalent | NEUROMARK Device Device, Electrosurgical, Cutting & Coagulation & Accessories | Safety and Efficacy Study of the Neurent Medical NEUROMARK System in Subjects With Chronic Rhinitis (MERIDIEN) | 2022 |
| 2022-09-23 | GlaxoSmithKline, LLC. | $19 | Food and Beverage | In-kind items and services | NUCALA Biological, IMMUNOLOGY | 2022 | |
| 2022-09-09 | Neurent Medical Limited | $4,208 | Research payment | Cash or cash equivalent | NEUROMARK Device Device, Electrosurgical, Cutting & Coagulation & Accessories | Safety and Efficacy Study of the Neurent Medical NEUROMARK System in Subjects With Chronic Rhinitis (MERIDIEN) | 2022 |
| 2022-09-08 | Regeneron Healthcare Solutions, Inc. | $20 | Food and Beverage | In-kind items and services | DUPIXENT Biological, INFLAMMATION AND IMMUNOLOGY | 2022 | |
| 2022-09-06 | Optinose US, Inc. | $18 | Food and Beverage | In-kind items and services | Xhance Drug, Otolaryngology (Ear, Nose, Throat) | 2022 | |
| 2022-08-23 | GlaxoSmithKline, LLC. | $17 | Food and Beverage | In-kind items and services | NUCALA Biological, IMMUNOLOGY | 2022 | |
| 2022-08-15 | Neurent Medical Limited | $115 | Food and Beverage | Cash or cash equivalent | NEUROMARK Device Device, Electrosurgical, Cutting & Coagulation & Accessories | 2022 | |
| 2022-08-02 | Regeneron Healthcare Solutions, Inc. | $21 | Food and Beverage | In-kind items and services | DUPIXENT Biological, INFLAMMATION AND IMMUNOLOGY | 2022 | |
| 2022-07-27 | Optinose US, Inc. | $3 | Food and Beverage | In-kind items and services | Xhance Drug, Otolaryngology (Ear, Nose, Throat) | 2022 | |
| 2022-07-19 | GlaxoSmithKline, LLC. | $16 | Food and Beverage | In-kind items and services | NUCALA Biological, IMMUNOLOGY | 2022 | |
| 2022-07-12 | Optinose US, Inc. | $21 | Food and Beverage | In-kind items and services | Xhance Drug, Otolaryngology (Ear, Nose, Throat) | 2022 | |
| 2022-06-24 | ALK-Abello, Inc | $23 | Food and Beverage | In-kind items and services | Odactra Drug, Allergy and Immunology | 2022 | |
| 2022-06-23 | Optinose US, Inc. | $6 | Food and Beverage | In-kind items and services | Xhance Drug, Otolaryngology (Ear, Nose, Throat) | 2022 | |
| 2022-06-07 | GlaxoSmithKline, LLC. | $18 | Food and Beverage | In-kind items and services | NUCALA Biological, IMMUNOLOGY | 2022 | |
| 2022-06-02 | Regeneron Healthcare Solutions, Inc. | $18 | Food and Beverage | In-kind items and services | DUPIXENT Biological, INFLAMMATION AND IMMUNOLOGY | 2022 | |
| 2022-05-26 | ALK-Abello, Inc | $27 | Food and Beverage | In-kind items and services | Ragwitek Drug, Allergy and Immunology | 2022 | |
| 2022-05-17 | Optinose US, Inc. | $22 | Food and Beverage | In-kind items and services | Xhance Drug, Otolaryngology (Ear, Nose, Throat) | 2022 | |
| 2022-05-14 | Regeneron Healthcare Solutions, Inc. | $67 | Food and Beverage | In-kind items and services | DUPIXENT Biological, INFLAMMATION AND IMMUNOLOGY | 2022 | |
| 2022-05-05 | Optinose US, Inc. | $5 | Food and Beverage | In-kind items and services | Xhance Drug, Otolaryngology (Ear, Nose, Throat) | 2022 | |
| 2022-05-03 | GlaxoSmithKline, LLC. | $16 | Food and Beverage | In-kind items and services | NUCALA Biological, IMMUNOLOGY | 2022 | |
| 2022-04-21 | Regeneron Healthcare Solutions, Inc. | $16 | Food and Beverage | In-kind items and services | DUPIXENT Biological, INFLAMMATION AND IMMUNOLOGY | 2022 | |
| 2022-04-19 | Intersect ENT, Inc. | $46 | Food and Beverage | In-kind items and services | SINUVA Drug, Otolaryngology (Ear, Nose, Throat) | 2022 | |
| 2022-04-12 | Optinose US, Inc. | $21 | Food and Beverage | In-kind items and services | Xhance Drug, Otolaryngology (Ear, Nose, Throat) | 2022 | |
| 2022-04-07 | Stryker Corporation | $120 | Food and Beverage | In-kind items and services | XPRESS ENT DILATION SYSTEM Device, ENTELLUS | 2022 | |
| 2022-03-30 | ALK-Abello, Inc | $22 | Food and Beverage | In-kind items and services | Odactra Drug, Allergy and Immunology | 2022 | |
| 2022-03-29 | Optinose US, Inc. | $4 | Food and Beverage | In-kind items and services | Xhance Drug, Otolaryngology (Ear, Nose, Throat) | 2022 | |
| 2022-03-15 | Optinose US, Inc. | $16 | Food and Beverage | In-kind items and services | Xhance Drug, Otolaryngology (Ear, Nose, Throat) | 2022 | |
| 2022-03-01 | GlaxoSmithKline, LLC. | $19 | Food and Beverage | In-kind items and services | NUCALA Biological, IMMUNOLOGY | 2022 | |
| 2022-02-28 | ALK-Abello, Inc | $44 | Food and Beverage | In-kind items and services | Odactra Drug, Allergy and Immunology | 2022 | |
| 2022-02-24 | Regeneron Healthcare Solutions, Inc. | $18 | Food and Beverage | In-kind items and services | DUPIXENT Biological, INFLAMMATION AND IMMUNOLOGY | 2022 | |
| 2022-02-16 | Optinose US, Inc. | $16 | Food and Beverage | In-kind items and services | Xhance Drug, Otolaryngology (Ear, Nose, Throat) | 2022 | |
| 2022-02-08 | ALK-Abello, Inc | $17 | Food and Beverage | In-kind items and services | Otiprio Drug, Otolaryngology | 2022 | |
| 2022-01-26 | ABBVIE INC. | $12 | Food and Beverage | In-kind items and services | UBRELVY Drug, NEUROSCIENCE | 2022 | |
| 2022-01-26 | Optinose US, Inc. | $4 | Food and Beverage | In-kind items and services | Xhance Drug, Otolaryngology (Ear, Nose, Throat) | 2022 | |
| 2022-01-11 | Optinose US, Inc. | $20 | Food and Beverage | In-kind items and services | Xhance Drug, Otolaryngology (Ear, Nose, Throat) | 2022 | |
| 2022-01-06 | Intersect ENT, Inc. | $11 | Food and Beverage | In-kind items and services | PROPEL Device, Otolaryngology (Ear, Nose, Throat) | 2022 | |
| 2021-12-14 | GlaxoSmithKline, LLC. | $18 | Food and Beverage | In-kind items and services | NUCALA Biological, IMMUNOLOGY | 2021 | |
| 2021-12-07 | Optinose US, Inc. | $17 | Food and Beverage | In-kind items and services | Xhance Drug, Otolaryngology (Ear, Nose, Throat) | 2021 | |
| 2021-12-01 | Optinose US, Inc. | $3 | Food and Beverage | In-kind items and services | Xhance Drug, Otolaryngology (Ear, Nose, Throat) | 2021 | |
| 2021-11-18 | ALK-Abello, Inc | $20 | Food and Beverage | In-kind items and services | Odactra Drug, Allergy and Immunology | 2021 | |
| 2021-11-16 | Optinose US, Inc. | $19 | Food and Beverage | In-kind items and services | Xhance Drug, Otolaryngology (Ear, Nose, Throat) | 2021 | |
| 2021-11-02 | ALK-Abello, Inc | $14 | Food and Beverage | In-kind items and services | Odactra Drug, Allergy and Immunology | 2021 | |
| 2021-10-26 | Aimmune Therapeutics, Inc. | $26 | Food and Beverage | In-kind items and services | PALFORZIA Biological, ALLERGY | 2021 | |
| 2021-10-21 | Stryker Corporation | $14 | Food and Beverage | In-kind items and services | LATERA Device, SPIROX | 2021 | |
| 2021-10-19 | Optinose US, Inc. | $17 | Food and Beverage | In-kind items and services | Xhance Drug, Otolaryngology (Ear, Nose, Throat) | 2021 | |
| 2021-10-14 | Stryker Corporation | $98 | Food and Beverage | In-kind items and services | XPRESS ENT DILATION SYSTEM Device, ENTELLUS | 2021 | |
| 2021-10-12 | GlaxoSmithKline, LLC. | $19 | Food and Beverage | In-kind items and services | NUCALA Biological, IMMUNOLOGY | 2021 | |
| 2021-10-08 | Optinose US, Inc. | $3 | Food and Beverage | In-kind items and services | Xhance Drug, Otolaryngology (Ear, Nose, Throat) | 2021 | |
| 2021-10-07 | AERIN MEDICAL INC. | $14,500 | Honoraria | Cash or cash equivalent | VIVAER STYLUS Device, EAR NOSE & THROAT | 2021 | |
| 2021-10-05 | Intersect ENT, Inc. | $41 | Food and Beverage | In-kind items and services | PROPEL Device, Otolaryngology (Ear, Nose, Throat) | 2021 | |
| 2021-09-28 | Optinose US, Inc. | $15 | Food and Beverage | In-kind items and services | Xhance Drug, Otolaryngology (Ear, Nose, Throat) | 2021 |
The latest 200 records of 263.
Research payments naming this person as principal investigator
CMS Open Payments: payments and transfers of value that drug and medical device makers and group purchasing organizations report to Medicare, program years 2019 on, as published by CMS (general, research and ownership records; refreshed by CMS each June and January). Links to other records on this site are by name (and state) only.
The area Census
County outline, the place (blue), the tract (orange) and the ZIP center (dot).
In Hoover, AL, county Jefferson County, AL, state Alabama; placed by its city name.
| Measure | Place (city or town) Hoover, AL | County Jefferson County, AL | State Alabama |
|---|---|---|---|
| Population B01003 | 92,642 | 667,755 | 5,086,768 |
| Population, 2020 census P1 | 92,606 | 674,721 | 5,024,279 |
| Median age B01002 | 38.4 | 37.7 | 39.3 |
| Under 18 B01001 | 24.5% | 22.9% | 22.2% |
| 65 and over B01001 | 16.6% | 16.8% | 17.8% |
| Households B11001 | 37,002 | 269,883 | 1,997,247 |
| Foreign born B05002 | 8.9% | 4.9% | 4.0% |
| Median household income B19013 | $109,253 | $66,388 | $63,999 |
| Median family income B19113 | $135,816 | $87,393 | $83,032 |
| Per capita income B19301 | $57,551 | $41,013 | $36,087 |
| Poverty rate B17001 | 5.1% | 15.7% | 15.6% |
| Unemployment rate B23025 | 3.5% | 4.7% | 4.7% |
| Civilian labor force B23025 | 49,732 | 326,550 | 2,367,787 |
| Mean commute (minutes) B08013 | 25.2 | 24.1 | 25.5 |
| Bachelor's degree or higher B15003 | 62.6% | 36.2% | 28.4% |
| Housing units B25001 | 39,594 | 310,789 | 2,337,265 |
| Owner-occupied B25003 | 71.1% | 63.9% | 70.2% |
| Renters B25003 | 28.9% | 36.1% | 29.8% |
| Median home value B25077 | $412,200 | $240,000 | $209,900 |
| Median gross rent B25064 | $1,457 | $1,193 | $1,007 |
| White, not Hispanic B03002 | 68.1% | 47.5% | 63.4% |
| Black B03002 | 18.5% | 42.1% | 25.6% |
| Hispanic or Latino B03002 | 4.6% | 5.5% | 5.6% |
| Asian B03002 | 5.9% | 1.9% | 1.4% |
| American Indian and Alaska Native B03002 | 0.1% | 0.1% | 0.3% |
Economy now FRED unemployment 3.5% in Sep 2026 (2.8% a year earlier); per capita personal income $59,754 in 2025, up 30% in five years (+4.7% after inflation); the state; Source: FRED, Federal Reserve Bank of St. Louis.
Data: IPUMS NHGIS (ACS 2020-2024 and the 2020 census); each figure links to its table for that area at data.census.gov. Records are placed by ZIP code and city name, not street address. More: everything FURP has in Hoover, AL.
Comments